Crossref journal-article
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences (341)
Abstract

The invasion of human malignant melanoma cells into the extracellular matrix (ECM) involves the accumulation of proteases at sites of ECM degradation where activation of matrix metalloproteases (MMP) occurs. Here, we show that when membrane type 1 MMP (MT-MMP) was overexpressed in RPMI7951 human melanoma cells, the cells made contact with the ECM, activated soluble and ECM-bound MMP-2, and degraded and invaded the ECM. Further experiments demonstrated the importance of localization of the MT-MMP to invadopodia. Overexpression of MT-MMP without invadopodial localization caused activation of soluble MMP-2, but did not facilitate ECM degradation or cell invasiveness. Up-regulation of endogenous MT-MMP with concanavalin A caused activation of MMP-2. However, concanavalin A treatment prevented invadopodial localization of MT-MMP and ECM degradation. Neither a truncated MT-MMP mutant lacking transmembrane (TM) and cytoplasmic domains (ΔTM MT-MMP ), nor a chimeric MT-MMP containing the interleukin 2 receptor α chain (IL-2R) TM and cytoplasmic domains (ΔTM MT-MMP /TM IL-2R ) were localized to invadopodia or exhibited ECM degradation. Furthermore, a chimera of the TM/cytoplasmic domain of MT-MMP (TM MT-MMP ) with tissue inhibitor of MMP 1 (TIMP-1/TM MT-MMP ) directed the TIMP-1 molecule to invadopodia. Thus, the MT-MMP TM/cytoplasmic domain mediates the spatial organization of MT-MMP into invadopodia and subsequent degradation of the ECM.

Bibliography

Nakahara, H., Howard, L., Thompson, E. W., Sato, H., Seiki, M., Yeh, Y., & Chen, W.-T. (1997). Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proceedings of the National Academy of Sciences, 94(15), 7959–7964.

Authors 7
  1. Hirokazu Nakahara (first)
  2. Linda Howard (additional)
  3. Erik W. Thompson (additional)
  4. Hiroshi Sato (additional)
  5. Motoharu Seiki (additional)
  6. Yunyun Yeh (additional)
  7. Wen-Tien Chen (additional)
References 31 Referenced 329
  1. 10.1152/physrev.1993.73.1.161
  2. 10.1146/annurev.cb.09.110193.002545
  3. 10.1007/BF00666155
  4. 10.1042/bst0220055
  5. 10.1177/10454411930040020401
  6. H S Azzam, E W Thompson Cancer Res 52, 4540–4544 (1992). / Cancer Res by Azzam H S (1992)
  7. W L Monsky, T Kelly, C Y Lin, Y Yeh, W G Stetler-Stevenson, S C Mueller, W-T Chen Cancer Res 53, 3159–3164 (1993). / Cancer Res by Monsky W L (1993)
  8. M Yu, H Sato, M Seiki, E W Thompson Cancer Res 55, 3272–3277 (1995). / Cancer Res by Yu M (1995)
  9. 10.1093/jnci/85.21.1758
  10. X Wang, X Fu, P D Brown, M J Crimmin, R M Hoffman Cancer Res 54, 4726–4728 (1994). / Cancer Res by Wang X (1994)
  11. 10.1016/0378-1119(89)90359-4
  12. 10.1074/jbc.270.10.5331
  13. 10.1038/370061a0
  14. 10.1073/pnas.92.7.2730
  15. 10.1016/0014-5793(96)00389-4
  16. 10.1074/jbc.271.15.9135
  17. K Imai, E Ohuchi, T Aoki, H Nomura, Y Fujii, H Sato, M Seiki, Y Okada Cancer Res 56, 2707–2710 (1996). / Cancer Res by Imai K (1996)
  18. 10.1074/jbc.272.4.2446
  19. W L Monsky, C-Y Lin, A Aoyama, T Kelly, S C Mueller, S K Akiyama, W-T Chen Cancer Res 54, 5702–5710 (1994). / Cancer Res by Monsky W L (1994)
  20. J R Morphy, T A Millican Curr Med Chem 2, 743–762 (1996). (10.2174/092986730203220224091658) / Curr Med Chem by Morphy J R (1996)
  21. 10.1073/pnas.87.21.8296
  22. 10.1007/BF01540646
  23. 10.1074/jbc.270.2.801
  24. 10.1083/jcb.119.5.1309
  25. 10.1002/jez.1402510206
  26. 10.1159/000468616
  27. 10.1074/jbc.271.44.27221
  28. 10.1074/jbc.272.12.7595
  29. 10.1007/BF01833261
  30. 10.1074/jbc.270.19.11555
  31. A R Mackay, D E Gomez, D W Cottam, R C Rees, A M Nason, U P Thorgeirsson BioTechniques 15, 1048–1051 (1993). / BioTechniques by Mackay A R (1993)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 10:42 a.m.)
Deposited 3 years, 4 months ago (April 13, 2022, 3:18 p.m.)
Indexed 1 month, 3 weeks ago (July 12, 2025, 6:58 p.m.)
Issued 28 years, 1 month ago (July 22, 1997)
Published 28 years, 1 month ago (July 22, 1997)
Published Online 28 years, 1 month ago (July 22, 1997)
Published Print 28 years, 1 month ago (July 22, 1997)
Funders 0

None

@article{Nakahara_1997, title={Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion}, volume={94}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.94.15.7959}, DOI={10.1073/pnas.94.15.7959}, number={15}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Nakahara, Hirokazu and Howard, Linda and Thompson, Erik W. and Sato, Hiroshi and Seiki, Motoharu and Yeh, Yunyun and Chen, Wen-Tien}, year={1997}, month=jul, pages={7959–7964} }